Merck's pause on an HIV program snowballs as a Gilead-partnered trial is shoved into limbo
Merck's
announcement last week that an experimental HIV combo therapy resulted in a
drop in immune cell counts, and its subsequent decision to ... |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.